Citius Pharmaceuticals Inc (NQ: CTXR )
0.5991
+0.0041
(+0.69%)
Streaming Delayed Price
Updated: 1:01 PM EDT, Aug 26, 2024
Add to My Watchlist
All News about Citius Pharmaceuticals Inc
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/08/08/CTXR.png?width=1200&height=800&fit=crop)
![](https://public.newsdirect.com/466510279/8SgX5cKG.png)
![](https://public.newsdirect.com/409919572/m7g3n0Bu.png)
![](https://public.newsdirect.com/252698575/AuR9rDe9.png)
Analysts Hunt for Undervalued Biotech Stocks
July 17, 2024
Via Newsfile
Via AB Newswire
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2024/05/21/CTXR.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/09/tea-on-a-tray.jpg)
![](https://investorplace.com/wp-content/uploads/2023/08/vfs1600-2.png)
![](https://investorplace.com/wp-content/uploads/2022/04/medical-device-stocks-hospital-stocks-healthcare-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://public.newsdirect.com/399624844/G3MtGOQh.png)
Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment
April 18, 2024
Via News Direct
Topics
Death
Exposures
Death
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Sidoti Events, LLC’s Virtual November Micro-Cap Conference
November 14, 2023
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/31/image32.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/31/ctxr.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/07/31/image45.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/31/csx_-_logo.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.